Lataa...
Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells
BACKGROUND: Renal cell carcinoma (RCC) is a common urological system malignancy lack of effective therapeutic options. Upregulation of the Bcl-2 proteins was correlated with poor prognosis of RCC, suggesting that BH-3 mimetics may be a promising treatment option. ABT-263 is a BH3 mimetic that posses...
Tallennettuna:
| Julkaisussa: | Cancer Manag Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868206/ https://ncbi.nlm.nih.gov/pubmed/33568941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S265788 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|